April 22, 2021
The Wolverine state removed prior authorization requirements for a preferred hepatitis C medication, increasing access to hepatitis C treatment for more Michiganders. Washington, D.C. (April 20, 2021) – The Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) today applauded Michigan Department of Health and...
Read More